021-51111890
购物车（）
sales@molnova.cn
PD 168568 dihydrochloride
CAS No. 1782532-06-2
PD 168568 dihydrochloride ( PD 168568 (dihydrochloride) )
产品货号. M26360 CAS No. 1782532-06-2
PD 168568 dihydrochloride is an orally active and selective antagonist of D4 dopamine receptor(Ki of 8.8 nM).
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ￥891 | 有现货 |
|
| 10MG | ￥1223 | 有现货 |
|
| 25MG | ￥2697 | 有现货 |
|
| 50MG | ￥4018 | 有现货 |
|
| 100MG | ￥5848 | 有现货 |
|
| 500MG | ￥12312 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称PD 168568 dihydrochloride
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述PD 168568 dihydrochloride is an orally active and selective antagonist of D4 dopamine receptor(Ki of 8.8 nM).
-
产品描述PD 168568 dihydrochloride is an orally active and selective antagonist of D4 dopamine receptor(Ki of 8.8 nM).(In Vitro):PD 168568 dihydrochloride has good selective for D4 receptor(Ki of 1842 nM for D2 receptor).(In Vivo):PD 168568 dihydrochloride inhibit amphetamine stimulated locomotor activity in the rat.
-
同义词PD 168568 (dihydrochloride)
-
通路GPCR/G Protein
-
靶点Dopamine Receptor
-
受体α4β2 nAChR; α7 nAChR
-
研究领域——
-
适应症——
化学信息
-
CAS Number1782532-06-2
-
分子量422.4
-
分子式C22H29Cl2N3O
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCl.Cl.Cc1ccc(cc1C)N1CCN(CCC2NC(=O)c3ccccc23)CC1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Stevens KE, Kem WR, Mahnir VM, Freedman R. Selective alpha7-nicotinic agonists normalize inhibition of auditory response in DBA mice. Psychopharmacology (Berl). 1998 Apr;136(4):320-7.
产品手册
关联产品
-
Rotigotine hydrochlo...
A non-selective agonist of the dopamine D3 receptor (Ki=0.71 nM); has 10-fold selectivity for the D3 receptor over the D2, D4, and D5 receptors and 100-fold selectivity for the D3 receptor over the D1 receptor.
-
Cariprazine HCl
Cariprazine HCl is an antipsychotic drug is a D3 and D2?receptor partial agonist((Ki of 0.085 nM and 0.49 nM respectively).
-
NMI 8739
NMI 8739 is an agonist of D2 autoreceptor. NMI 8739 reduces NO production and elicits concentration-dependent suppression of CCL-20, MCP-1 and IL-6 release.
